Rahimtoola SH. Importance of diagnosing hibernating myocardium: How and in whom?. J Am Coll Cardiol 1997;30:1701–1706.
Bax JJ, Wijns W, Cornel JH, Visser FC, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451–1460.
Beller GA, Ragosta M, Watson DD, Gimple LW. Myocardial thallium-201 scintigraphy for assessment of viability in patients with severe left ventricular dysfunction. Am J Cardiol 1992;70:18E–22E.
Udelson JE, Coleman PS, Metherall J et al. Predicting recovery of severe regional ventricular dysfunction; Comparison of resting scintigraphy with 201T1 and 99Tc-sestamibi. Circulation 1994;89:2552–2561.
Schelbert HR. Measurments of myocardial metabolism in patients with ischemic heart disease. Am J Cardiol 1998;82:61K–67K.
Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with Iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995;36:1022–1030.
Cornel JH, Bax JJ, Fioretti PM. Assessment of myocardial viability by dobutamine stress echocardiography. Curr Opin Cardiol 1996;11:621–626.
Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium. Circulation 1993;87:1–20.
Gibson RS, Watson DD, Taylor GJ et al. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1983;1:804–815.
Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987;10:557–567.
Ohtani H, Tamaki N, Yonekura Y et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394–399.
Gutman J, Berman DS, Freeman M et al. Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy: Relationship to the degree of coronary artery stenosis. Am Heart J 1983;106:989–995.
Kiat H, Berman DS, Maddahi J et al. Late reversibility of tomographic myocardial thallium-201 defects: An accurate marker of myocardial viability. J Am Coll Cardiol 1988;12:1456–1463.
Brunken RC, Mody F, Hawkins RA, Nienaber CA, Phelps ME, Schelbert HR. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201T1 defects. Circulation 1992;86:1357–1369.
Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141–146.
Tamaki N, Ohtani H, Yonekura Y et al. Significance of fill-in after thallium-201 reinjection following delayed imaging: Comparison with regional wall motion and angiographic findings. J Nucl Med 1990;31:1617–1624.
Van Eck-Smit BLF, van der Wall EE, Kuijper AFM, Zwinderman AH, Pauwels EKJ. Immediate thallium-201 reinjection following stress imaging: A time-saving approach for detection of myocardial viability. J Nucl Med 1993;34:737–743.
Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V. Stress-induced reversible and mild-to-moderate irreversible thallium defects: Are they equally accurate for predicting recovery of regional left ventricular function after revascularization?. Circulation 1998;98:501–508.
Bax JJ, Vanoverschelde JLJ, Cornel JH et al. Optimal viability criteria on thallium-201 reinjection SPECT to predict improvement of function after revascularization [abstract]. J Am Coll Cardiol 1999;33(Suppl A):416A.
Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18-F-fluorodeoxyglucose. Circulation 1991;83:26–37.
Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO. Regional thallium uptake in irreversible defects magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992;85:627–634.
Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution Tl-201 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630–1641.
Maddahi J, Berman DS. Reverse redistribution of thallium-201. J Nucl Med 1995;36:1019–1021.
Marin-Neto JA, Dilsizian V, Arrighi JA et al. Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution. Circulation 1993;88:1736–1745.
Sciagra R, Pupi A, Pellegri M et al. Prediction of post-revascularization functional recovery of asynergic myocardium using quantitative thallium-201 rest-redistribution tomography: Has the reverse redistribution pattern an independent significance?. Eur J Nucl Med 1998;25:594–600.
Tamaki N, Ohtani H, Yamashita K et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: Comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991;32:673–678.
Dilsizian V, Perrone-Filardi P, Arrighi JA et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993;88:941–952.
Dilsizian V, Arrighi JA, Diodati JG et al. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-Sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Circulation 1994;89:578–587.
Cuocolo A, Pace L, Ricciardelli B, Ciariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: Comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992;33:505–511.
Cuocolo A, Maurea S, Pace L et al. Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: Comparison with rest-redistribution thallium-201 scintigraphy. Eur J Nucl Med 1993;20:1186–1192.
Dondi M, Tartagni F, Fallani F et al. A comparison of rest sestamibi and rest-redistribution single photon emission tomography: possible implications for myocardial viability detection in infarcted patients. Eur J Nucl Med 1993;20:26–31.
Vanoverschelde JLJ, D’Hondt AM, Marwick T et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432–442.
Qureshi U, Nagueh SF, Afridi I et al. Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. Circulation 1997;95:626–635.
Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995;91:990–998.
Arnese M, Cornel JH, Salustri A et al. Prediction of improvement of regional left ventricular function after surgical revascularization: A comparison of low-dose dobutamine echocardiography with 201-TL SPECT. Circulation 1995;91:2748–2752.
Cornel JH, Bax JJ, Elhendy A et al. Agreement and disagreement between “metabolic viability” and “contractile reserve” in akinetic myocardium. J Nucl Cardiol 1999;6:383–388.
Baumgartner H, Porenta G, Lau Y et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT. Correlation with explanted hearts. J Am Coll Cardiol 1998;32:1701–1708.
Bax JJ, Poldermans D, Visser FC et al. Delayed recovery of hibernating myocardium after surgical revascularization: Implications for discrepancy between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability. J Nucl Cardiol. In press 1999.
Bax JJ, Cornel JH, Visser FC et al. Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization. J Nucl Med 1998;39:1481–1486.
Gunning MG, Anagnostopoulos C, Knight CJ et al. Comparison of 201Tl, 99mTctetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998;98:1869–1874.
Pace L, Perrone-Filardi P, Mainenti P et al. Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium-201 scintigraphy: Optimal image analysis. J Nucl Med 1998;39:1869–1874.
He ZX, Darcourt J, Guignier A et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med 1993;34:1472–1477.
Iskandrian AS, Hakki A, Kane SA et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol 1983;51:1312–1316.
Eitzman D, Al-Aouar ZR, Kanter HL et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559–565.
Di Carli M, Davidson M, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527–533.
Vom Dahl J, Altehoefer C, Sheehan FH et al. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med 1997;38:742–748.
Tamaki N, Kawamoto M, Takahashi N et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993;22:1621–1627.
Lee KS, Marwick TH, Cook SA et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687–2694.
Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995;75:759–762.
Gioia G, Milan E, Giubbini R, DePace N, Heo J, Iskandrian AS. Prognostic value of tomographic rest-redistribution thallium-201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1996;3:150–156.
Cuocolo A, Petretta M, Nicolai E, Pace L, Bonaduce D, Salvatore M, Trimarco B. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998;25:60–68.
Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathic and residual myocardial viability. Circulation 1997;96:793–800.
Pasquet A, Robert A, D’Hondt AM, Dion R, Melin JA, Vanoverschelde JLJ. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999;100:141–148.
Bax JJ, Wijns W. FDG imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?. J Nucl Med. In press 1999.
Bax JJ, Cornel JH, Visser FC et al. Prediction of recovery of myocardial dysfunction following revascularization; Comparison of F18-fluorodeoxyglucose/thallium-201 single photon emission computed tomography, thallium-201 stress-reinjection single photon emission computed tomography and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558–564.
Haque T, Furukawa T, Takahashi M, Kinoshita M. Identification of hibernating myocardium by dobutamine stress echocardiography: Comparison with thallium-201 reinjection imaging. Am Heart J 1995;130:553–563.
Taki J, Nakajima K, Matsunari I et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997;38:1503–1510.
Lipiecki J, Maublant JC, Citron B et al. Comparable uptake of thallium-201 and technetium-99m MIBI in hibernating and “maimed” myocardium. Am J Cardiol 1997;79:940–943.
Gürsürer M, Pinarli AE, Aksoy M et al. Assessment of viable myocardium and prediction of postoperative improvement of left ventricular function in patients with severe left ventricular dysfunction by quantitative planar stress-redistribution-reinjection 201-Tl imaging. Int J Cardiol 1997;58:179–184.
Kostopoulos KG, Kranidis AI, Bouki KP et al. Detection of myocardial viability in the prediction of improvement in left ventricular function after successful coronary revascularization by using the dobutamine stress echocardiography and quantitative SPECT rest-redistribution-reinjection 201T1 imaging after dipyridamole infusion. Angiology 1996;47:1039–1046.
Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991;32:1718–1724.
Marzullo P, Parodi O, Reisenhofer B et al. Value of rest thallium-201/technetium-99m Sestamibi and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166–172.
Alfieri O, La Canna G, Giubinni R, Pardini A, Zogno M, Fucci C. Recovery of myocardial function. Eur J Cardiothorac Surg 1993;7:325–330.
Charney R, Schwinger ME, Chun J et al. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994;128:864–869.
Perrone-Filardi P, Pace L, Prastaro M et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. Circulation 1996;94:2712–2719.
Nagueh SF, Vaduganathan P, Ali N et al. Identification of hibernating myocardium: Comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997;29:985–993.
Matsunari I, Fujino S, Taki J et al. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: Comparison with rest-redistribution thallium-201. J Am Coll Cardiol 1997;29:1226–1233.
Cuocolo A, Nicolai E, Petretta M et al. One-year effect of myocardial revascularization on resting left ventricular function and regional thallium uptake in chronic CAD. J Nucl Med 1997;38:1684–1692.
Bax JJ, Visser FC, Van Lingen A, Sloof GW, Cornel JH, Visser CA. Comparison between 360° and 180° data sampling in thallium-201 rest-redistribution single-photon emission tomography to predict functional recovery after revascularization. Eur J Nucl Med 1997;24:516–522.
Sciagra R, Bisi G, Santoro GM et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997;30:384–391.
Marzullo P, Sambucetti G, Parodi O et al. Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: Comparison with postrevascularization functional recovery. J Nucl Cardiol 1995;2:309–316.
Matsunari I, Fujino S, Taki J et al. Significance of late redistribution thallium-201 imaging after rest injection for detection of viable myocardium. J Nucl Med 1997;38:1073–1078.
Sciagra R, Santoro GM, Bisi G, Pedenovi P, Fazzini PF, Pupi A. Rest-redistribution thallium-201 SPECT to detect myocardial viability. J Nucl Med 1998;39:384–390.
Pace L, Perrone-Filardi P, Mainenti P et al. Combined evaluation of rest-redistribution thallium-201 tomography and low-dose dobutamine echocardiography enhances the identification of viable myocardium in patients with chronic coronary artery disease. Eur J Nucl Med 1998;25:744–750.
Senior R, Glenville B, Basu S et al. Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction. Br Heart J 1995;74:358–364.
Gunning MG, Anagnostopoulos C, Davies G et al. Simultaneous assessment of myocardial viability and function for the detection of hibernating myocardium using ECG-gated 99Tcm-tetrofosmin emission tomography: A comparison with 201T1 emission tomography combined with cine magnetic resonance imaging. Nucl Med Commun 1999;20:209–214.
Sicari R, Varga A, Picano E, Borges AC, Gimelli A, Marzullo P. Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy to improve viability detection. Am J Cardiol 1999;83:6–10.